Two U.S. Representatives from Florida are calling for a Medicaid fraud investigation into the Florida Agency for Health Care Administration and political groups that campaigned against the state’s adult-use cannabis legalization initiative. The lawmakers want the U.S. Department of Health and Human Services Inspector General and the Center for Medicare & Medicaid Services to investigate a legal settlement between Florida and Centene, which the lawmakers believe was “inappropriately diverted to unrelated political committees,” including the Hope Florida Foundation. The letter tracks settlements and donations that started with a settlement related to Centene overbilling Florida’s taxpayers, resulting in the company sending $10 million to Hope Florida, which dispersed the funding into political committees in a manner that “appears to run afoul of federal law,” the lawmakers wrote. Florida voters ultimately rejected the constitutional amendment to legalize adult-use cannabis. < Back Federal Lawmakers Call for Medicaid Fraud Investigation Into Florida Anti-Cannabis Political Group May 19, 2025 Source: Graham Abbott Ganjapreneur Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Two U.S. Representatives from Florida — Democratic Reps. Kathy Castor and Darren Soto — are calling on the federal government to launch a Medicaid fraud investigation into the Florida Agency for Health Care Administration and political groups that last year campaigned against the state’s adult-use cannabis legalization initiative. In a letter sent last week, the lawmakers called on the U.S. Department of Health and Human Services Inspector General and the Center for Medicare & Medicaid Services to investigate a legal settlement between Florida and the state’s largest Medicaid managed care operator, Centene, which the lawmakers believe was “inappropriately diverted to unrelated political committees,” including the Hope Florida Foundation, which was founded by Florida First Lady Casey DeSantis, wife of Gov. Ron DeSantis (R). The letter tracks a series of settlements, payments, and donations that started with a settlement related to Centene overbilling Florida’s taxpayers and resulted in the company sending $10 million to Hope Florida, which dispersed the funding into political committees in a manner that “appears to run afoul of federal law,” the lawmakers wrote. “As members of the U.S. House Energy and Commerce Committee that provides oversight of Medicaid, we can assure you that Congress is very focused on waste, fraud, and abuse of Medicaid dollars. Any unlawful diversion of Medicaid dollars in Florida means that the state is less able to provide services to our neighbors who rely on Medicaid and support the providers who serve them.” — Excerpt from the letter “Medicaid is a federal/state partnership, and the federal government may be entitled to recoup funds from the legal settlement and improperly diverted funds as well,” the lawmakers wrote in the letter. House Republicans say they want to root out waste, fraud, and abuse in government? Here’s their opportunity. @RepDarrenSoto and I are calling for a federal investigation into a shady $10M diversion of Medicaid funds in FL — money that was meant to help families afford health… — U.S. Rep. Kathy Castor (@USRepKCastor) May 15, 2025 Florida voters ultimately rejected the constitutional amendment to legalize adult-use cannabis — the amendment required 60% support to pas,s but fell short with just under 56% of the vote. < Previous Next > Recent Reviews Cookies & Alt Sol "Ridgeline Lantz" Strain Review - Takoma Wellness Center Ridgeline Lantz, cultivated by Alt Sol and currently available at Takoma Wellness Center, exudes an impressive pedigree. With its origins... Watermelon Sugar, High: Fade Co.'s Live Resin Gummies Reviewed There's a running joke about Harry Styles' summer smash that the man himself has cheerfully leaned into: nobody is entirely sure what "watermelon sugar" is, only that it sounds fantastic and you want more of it. Fade Co. seems to have taken that ambiguity as a design brief. Their new live resin gummies don't just borrow the fruit - they capture the whole breezy, sun-warmed, slightly-too-good-to-analyze feeling the song trades in, then pack it ten to a tin... Platinum TK - Green Theory Dispensary Platinum TK is an indica-dominant hybrid from the skilled cultivators at Alt Sol that offers a robust and relaxing experience. Currently... 1 2 3 4 5

The potential reclassification of cannabis to Schedule III would likely remove businesses from the restrictive Internal Revenue Code Section 280E, allowing for the deduction of ordinary operating expenses and significantly improving cash flow. To capitalize on this shift, operators should prioritize operational speed, maintain inventory discipline, and ensure financial transparency to navigate increased competition and rising deal velocity. < Back How Cannabis Operators Can Win in a Post-280E Market Mar 5, 2026 Source: Adam Stettner MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link For years, cannabis operators have been forced to plan around a tax code designed to punish them. Internal Revenue Code Section 280E distorted margins, constrained reinvestment and turned basic operating expenses into permanent cost disadvantages. With cannabis potentially moving to Schedule III, that constraint may finally lift. Key insights - *Treat 280E relief like a starting gun, not a bonus.* Speed beats savings if the market shifts quickly. - *Win the 30–60 day window.* If you can’t adjust production, inventory mix, and distribution fast, the advantage evaporates. - *Inventory discipline becomes a weapon.* Pulling forward inventory or receivables can outperform “waiting for certainty.” - *Clean financials unlock deal leverage.* Accessories often deliver strong margins and predictable attachment when merchandised near flower and pre-rolls. - *Merchandising and staff scripting drive conversion:* In a faster M&A environment, readiness becomes pricing power. This won’t be a universal win. It’s a catalyst. But here’s the hard truth: Federal reclassification that removes 280E would not be a universal win. It would be a catalyst. And like every other catalyst in cannabis, it will reward proactive preparation. Rescheduling won’t change just tax treatment. It will change behavior across the market. Cash flow will improve, but unevenly. Pricing advantages will compress faster than many expect. Buyers and vendors will become more selective. Acquisition and partnership conversations will start earlier and move quicker. Operators who treat 280E repeal as a windfall will risk getting overtaken by those who treat it as a starting gun. The most immediate benefit of reclassification from Schedule I to Schedule III will be straightforward: Cannabis businesses can deduct ordinary operating expenses like rent, payroll, marketing, and interest, dropping effective federal tax rates from punitive levels well above 50 percent to something closer to the standard corporate range — possibly less than half of what they currently pay. That will free up real cash. But what matters more than the relief itself is what operators do with it. Speed and flexibility will matter more than tax relief Operators’ first question shouldn’t be tax-related; it should focus on operational speed and flexibility. When market conditions shift, can you quickly adapt? Improving margins often reshape demand, opening opportunities competitors are quick to capture if you don’t. Simply put, advantages don’t linger. If you can’t ramp production, adjust inventory to the right mix at the right time, fulfill demand as it emerges or expand distribution within the next 30–60 days — not the next fiscal year — then any theoretical tax savings won’t translate into lasting gains. The market around us will evolve more than just tax treatment. Inventory is the second pressure point Inventory strategy is the second pressure point. Rescheduling will alter buying behavior across the supply chain. Some buyers will stock up earlier. Others will push harder on price. Operators with the capital flexibility to build inventory ahead of compression tend to win twice: They secure better pricing and stronger positioning. Those who wait often find themselves choosing between starving day-to-day operations or missing the window entirely. Think about how to use capital to pull forward inventory or receivables. This will make a difference. The operators that can pull forward thirty days of inventory or bring in accounts receivable forty-five to sixty days sooner will do much better than those that keep the status quo. Competition tightens when everyone accelerates Competition is the third reality operators need to confront. Rescheduling will not thin the field; it will tighten it. Better-capitalized peers will invest in capacity, inventory, marketing, and market share. Standing still becomes more expensive when everyone else accelerates. Operators should be stress-testing their ability to adjust production, realign buying and selling cycles, refine pricing, reposition brands, and defend key relationships quickly when pressure increases. Sometimes operators react inappropriately to the increased competition, making bad decisions like misusing the tax relief or overspending in the wrong areas. Be smart about how you compete on strategy, and plan now for what you might want to do when the change takes effect. Deal velocity is rising. Your books have to be ready. Perhaps the most underappreciated shift will be in deal velocity. Conversations about mergers and acquisitions are beginning to ramp up. Clean financials, disciplined receivables, and organized payables are no longer best practices; they are prerequisites. If your books aren’t ready, deals won’t wait. Optionality disappears. Specialized accounting firms understand cannabis from both an operator’s perspective and that of institutional buyers. Engage them. Cleaning up your financials is neither burdensome nor expensive, and many cannabis-focused certified public accountants will offer an initial consultation at no cost. Capital won’t reprice overnight, so build options now This is also where expectations need to stay grounded. Rescheduling will not mean banks suddenly rush to serve the industry. Traditional institutions will remain cautious. Institutional capital will take time to recalibrate. The gap between improved economics and slower capital markets is where advantage is created. Operators who already have non-dilutive capital in place can act while others are still waiting for permission. Use debt deliberately or not at all Debt, in this environment, will be reframed. Used responsibly, it becomes a strategic tool allowing operators to move ahead of the market instead of reacting behind it. Liquidity doesn’t just smooth operations. It also fuels growth and preserves choice. Schedule III won’t reward everyone evenly. Operators who prepare with financial discipline, aligning buy/sell cycles, right-sizing inventory with the right mix of products, and securing flexible capital will gain an edge over those that do not. Companies that do not prepare will face even tighter competition, continued compressed margins, and decisions made under pressure rather than on their own terms. Seize strategic opportunities There is an opportunity here, and it will reward those who are most strategic. The end of 280E will close a painful chapter. What comes next will define the next decade of the cannabis market. ------------------------------ 1. Would Schedule III automatically end 280E for cannabis operators? 280E applies to trafficking in Schedule I or II substances, so moving cannabis to Schedule III would generally remove cannabis businesses from 280E’s scope—but operators should watch for IRS implementation guidance and timing details. 2. What should operators do first with potential 280E relief? Prioritize operational speed: shorten decision cycles, improve forecasting, and build the ability to adjust production, inventory, and distribution within 30–60 days. 3. Why will inventory strategy matter more after rescheduling? If margins and pricing compress quickly, the operators who can buy smart, time builds, and protect cash conversion cycles can secure share while others scramble. 4. Will banks and institutional capital move quickly after Schedule III? Not necessarily. Traditional institutions may remain cautious even if economics improve, creating a window where prepared operators can act faster than competitors. Expert answers Would Schedule III automatically end 280E for cannabis operators? 280E applies to trafficking in Schedule I or II substances, so moving cannabis to Schedule III would generally remove cannabis businesses from 280E’s scope, but operators should watch for IRS implementation guidance and timing details. What should operators do first with potential 280E relief? Prioritize operational speed: shorten decision cycles, improve forecasting, and build the ability to adjust production, inventory, and distribution within thirty to sixty days. Why will inventory strategy matter more after rescheduling? If margins and pricing compress quickly, the operators who can buy smart, time builds, and protect cash conversion cycles can secure share while others scramble. Will banks and institutional capital move quickly after Schedule III? Not necessarily. Traditional institutions may remain cautious even if economics improve, creating a window where prepared operators can act faster than competitors. ------------------------------ [image: Adam Stettner, founder and CEO, FundCanna] Adam Stettner has more than thirty years’ experience in business, strategy, and leadership at both public and private companies. In 2021, he founded FundCanna and serves as its chief executive officer. For the previous twenty years, he ran companies that collectively provided nearly $20 billion in on-balance-sheet funding to consumers and small- to mid-sized businesses, typically in underserved markets. FundCanna provides short-term funding to all sectors of the cannabis industry. Since inception, the firm has deployed nearly $250 million in capital to more than 4,300 accounts. < Previous Next > Recent Reviews Cookies & Alt Sol "Ridgeline Lantz" Strain Review - Takoma Wellness Center Ridgeline Lantz, cultivated by Alt Sol and currently available at Takoma Wellness Center, exudes an impressive pedigree. With its origins... Watermelon Sugar, High: Fade Co.'s Live Resin Gummies Reviewed There's a running joke about Harry Styles' summer smash that the man himself has cheerfully leaned into: nobody is entirely sure what "watermelon sugar" is, only that it sounds fantastic and you want more of it. Fade Co. seems to have taken that ambiguity as a design brief. Their new live resin gummies don't just borrow the fruit - they capture the whole breezy, sun-warmed, slightly-too-good-to-analyze feeling the song trades in, then pack it ten to a tin... Platinum TK - Green Theory Dispensary Platinum TK is an indica-dominant hybrid from the skilled cultivators at Alt Sol that offers a robust and relaxing experience. Currently... 1 2 3 4 5

Everything about KC 33: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back KC 33 Strain Review Type Hybrid THC % 18% Dominant Terpene Energy NA Relaxed, Euphoric Overview KC 33 is a 60/40 indica-dominant hybrid developed by KC Brains in Holland. This strain was created in 1993, with its name "33" specifically marking the age of the breeder at the time of its conception. It is recognized for its unique genetic lineage and its suitability for specific environmental conditions. Effects KC 33 is an indica-dominant hybrid that delivers weightless cerebral effects, offering a clear-headed and uplifting high that remains focused in the mind without any heavy or sedating body sensations. This profile supports sustained energy levels, making the strain ideal for daytime use and productivity. The terpene profile features limonene, which provides mood-elevating benefits and a zesty aroma, alongside myrcene for its calming qualities and caryophyllene for potential anti-inflammatory relief. These attributes make KC 33 particularly effective for individuals seeking mood enhancement and relief from physical inflammation while avoiding lethargy. Positive Effects Side Effects Common Uses Relaxed 75% Happy 37% Euphoric 50% Uplifted 0% Talkative 0% Creative 0% Energetic 0% Focused 0% Giggly 0% Tingly 37% Hungry 37% Sleepy 0% stress, pain, nausea, arthritis, add/adhd Dry Mouth 12% Dry Eyes 0% Dizzy 12% Paranoid 0% Anxious 0% Hungry 37% Tingly 37% Sleepy 0% Appearance The plants are known for their robust growth, often reaching impressive heights when grown outdoors. They produce dense, resinous buds that reflect their heavy Afghani influence. Aroma KC 33 features a distinct and refreshing zesty lemon aroma, complemented by subtle earthy and spicy undertones characteristic of its landrace and Haze ancestors. Flavor The flavor profile is dominated by a sharp citrus and lemon zest on the inhale, followed by a smooth, herbal, and slightly sweet finish on the exhale. Lineage This complex hybrid is a three-way cross between Afghani, Haze, and a hardy Ukrainian landrace strain. This combination results in a plant that balances the structural stability of landrace genetics with the potency of Haze and Afghani. Terpene Profile - Limonene: Provides the prominent citrus and lemon scent while elevating mood. - Myrcene: Contributes to the herbal notes and supports the strain's relaxing qualities. - Caryophyllene: Adds a touch of spice and offers potential anti-inflammatory benefits.Effects Despite its indica dominance, KC 33 is famous for delivering weightless cerebral effects. It provides a clear-headed, uplifting high that remains focused in the mind without sinking into a heavy or sedating body sensation, making it suitable for daytime use. Cultivation Preferences Specifically bred for the outdoor cultivator, KC 33 is highly resilient and thrives in wet, cooler climates where other strains might struggle. - Flowering Time: Approximately 8 to 10 weeks. - Yield: High, especially when given ample space to grow outdoors. - Environment: Highly resistant to mold and rot, making it ideal for Atlantic or Northern European climates.Origin The strain originated in Holland, developed by the breeder KC Brains. Seed Suppliers Authentic seeds for KC 33 can typically be sourced directly from KC Brains or through various international seed banks such as Seedsman and Attitude Seedbank. Conclusion KC 33 stands out as a specialized hybrid that offers a unique cerebral experience without physical heaviness. Its exceptional resistance to damp and cool weather makes it a legendary choice for outdoor growers in challenging climates. Previous Next

Everything about Blue Kripple: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back Blue Kripple Strain Review Type Indica THC % 14% Dominant Terpene Energy Myrcene Relaxed, Sleepy Overview Blue Kripple is a potent indica-dominant hybrid celebrated for its therapeutic properties and impressive yields. Developed by Dr. Krippling, this strain combines the medicinal strength of Medicine Man and Blue Rhino with the high-production capabilities of Big Bud. Effects Blue Kripple is a powerful indica-dominant hybrid that delivers a profound full-body stone and deep physical relaxation, making it ideal for low-energy activities and nighttime use. Its sedative nature is highly effective for managing chronic pain, muscle spasms, stress, and insomnia, providing a restorative "kryppling" effect for medical patients. The strain's complex terpene profile is led by myrcene, which enhances its herbal scent and sedative properties, followed by alpha-pinene for a fresh pine aroma and potential mental clarity, and caryophyllene, which adds a spicy kick and anti-inflammatory benefits. Together, these elements create a potent therapeutic experience that cradles the user in a state of tranquil sedation. Positive Effects Side Effects Common Uses Relaxed 60% Happy 40% Euphoric 50% Uplifted 0% Talkative 0% Creative 0% Energetic 0% Focused 0% Giggly 0% Tingly 50% Hungry 0% Sleepy 60% pain, anxiety, insomnia, headache, headaches, eye_pressure Dry Mouth 20% Dry Eyes 10% Dizzy 40% Paranoid 20% Anxious 0% Hungry 0% Tingly 50% Sleepy 60% Appearance This strain is known for producing dense, oversized colas that are heavily coated in resin. The buds typically display deep forest green hues with subtle blue undertones, complemented by a thick layer of frosty white trichomes and vibrant orange hairs. Aroma Blue Kripple emits a complex and inviting fragrance. It features a dominant base of sweet berries and earthy pine, rounded out by pungent, slightly sour notes that become more apparent when the buds are broken apart. Flavor The flavor profile is rich and smooth, offering a delightful blend of sweet blueberries and herbal spices. On the exhale, users often notice a lingering woody aftertaste with hints of damp earth. Lineage The genetic heritage of Blue Kripple is a three-way cross between Medicine Man, Blue Rhino, and Big Bud. This lineage ensures a stable, high-yielding plant that retains the profound physical relaxation associated with its indica ancestors. Terpene Profile - Myrcene: The primary terpene, contributing to the strain's herbal scent and sedative effects. - Alpha-Pinene: Adds a fresh pine aroma and may help with mental clarity. - Caryophyllene: Provides a spicy kick and potential anti-inflammatory benefits.Effects With its heavy indica influence, Blue Kripple delivers a powerful full-body stone. It is highly effective at "cradling" the user in a state of deep relaxation, making it an excellent choice for evening or nighttime use. It is frequently sought after by those looking to manage chronic pain, muscle spasms, stress, and insomnia. Cultivation Preferences Blue Kripple is a favorite among growers due to its massive yields and relatively easy maintenance. - Flowering Time: Approximately 7 to 9 weeks. - Yield: Exceptionally high, often exceeding 450-550g/m2 indoors and up to 650g per plant outdoors. - Environment: It thrives in both indoor and outdoor settings, though it requires support for its heavy branches as the colas reach full maturity.Origin The strain was originated and stabilized in the United Kingdom by the breeders at Dr. Krippling Seeds. Seed Suppliers Authentic feminized seeds can be sourced directly from Dr. Krippling Seeds or through major international seed banks such as Seedsman, Gorilla Seeds, and MSNL. Conclusion Blue Kripple stands out as a top-tier indica for both cultivators and consumers. By balancing massive production with intense physical sedation and a pleasant berry flavor, it remains a reliable staple for medical patients and recreational users seeking a deep, restorative "kryppling" effect. Previous Next

The cannabis company reported a third-quarter operating cash flow of $6 million. < Back Cresco Labs Reports $165M in Q3 Revenue; Net Loss of $22M Nov 5, 2025 Source: Staff Cannabis Business Times Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The cannabis company also reported a third-quarter operating cash flow of $6 million. < Previous Next > Recent Reviews Cookies & Alt Sol "Ridgeline Lantz" Strain Review - Takoma Wellness Center Ridgeline Lantz, cultivated by Alt Sol and currently available at Takoma Wellness Center, exudes an impressive pedigree. With its origins... Watermelon Sugar, High: Fade Co.'s Live Resin Gummies Reviewed There's a running joke about Harry Styles' summer smash that the man himself has cheerfully leaned into: nobody is entirely sure what "watermelon sugar" is, only that it sounds fantastic and you want more of it. Fade Co. seems to have taken that ambiguity as a design brief. Their new live resin gummies don't just borrow the fruit - they capture the whole breezy, sun-warmed, slightly-too-good-to-analyze feeling the song trades in, then pack it ten to a tin... Platinum TK - Green Theory Dispensary Platinum TK is an indica-dominant hybrid from the skilled cultivators at Alt Sol that offers a robust and relaxing experience. Currently... 1 2 3 4 5

Everything about Blue Trane: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back Blue Trane Strain Review Type Hybrid THC % 7% Dominant Terpene Energy NA Unknown Overview Blue Trane is a rare and enigmatic cultivar with a storied past, originally discovered by the head grower of Colorado Seed Inc. while working with local genetics in Hawaii. Since its acquisition, the strain has been stabilized and cultivated across various regions, maintaining its reputation as a unique, indica-dominant treasure. Effects Blue Trane is a potent indica-dominant strain celebrated for its unique dual-action effects, beginning with an unexpectedly heady, almost psychedelic cerebral stimulus that enhances sensory perception. This trippy mental state quickly transitions into a powerful, long-lasting body high that "sticks to the bones," making it ideal for low-energy activities and evening use. Its therapeutic profile is well-suited for melting away physical tension and providing deep relaxation for those managing stress or chronic pain. The strain’s complex terpene profile is led by myrcene, which contributes to its earthy aroma and profound sedative properties; pinene, which adds a fresh forest scent and provides a touch of mental clarity; and caryophyllene, which offers spicy undertones and supports body-focused relief. Together, these elements make Blue Trane a standout choice for connoisseurs seeking a multi-layered experience that balances intense mental stimulation with heavy physical sedation. Positive Effects Side Effects Common Uses Relaxed 0% Happy 0% Euphoric 0% Uplifted 0% Talkative 0% Creative 0% Energetic 0% Focused 0% Giggly 0% Tingly 0% Hungry 0% Sleepy 0% Unknown Dry Mouth 0% Dry Eyes 0% Dizzy 0% Paranoid 0% Anxious 0% Hungry 0% Tingly 0% Sleepy 0% Appearance This strain typically develops dense, medium-sized buds characterized by a deep forest green hue, often accented by subtle blue or purple undertones. A generous coating of frosty trichomes gives the flower a shimmering, sticky texture, while bright orange pistils provide a sharp visual contrast. Aroma Blue Trane features a complex aromatic profile that blends traditional earthy notes with a sweet, berry-like fragrance. Many users detect hints of spicy herbs and a faint floral trail that reflects its tropical Hawaiian roots. Flavor The taste mirrors its scent, offering a smooth smoke with a prominent sweet blueberry flavor on the inhale. This is complemented by a woody, slightly spicy exhale that leaves a pleasant, lingering herbal aftertaste. Lineage The exact genetic map of Blue Trane remains somewhat mysterious, as it was sourced from local Hawaiian "cuts" rather than a documented laboratory cross. However, its characteristics strongly suggest a heritage involving Blueberry and a heavy indica landrace, refined through stabilization by Colorado Seed Inc. Terpene Profile - Myrcene: The dominant terpene, contributing to the strain’s earthy scent and profound relaxing effects. - Pinene: Adds a fresh, forest-like aroma and helps balance the heavy sedation with slight mental clarity. - Caryophyllene: Provides a spicy undertone and supports the strain’s body-focused therapeutic benefits.Effects Blue Trane is celebrated for its dual-action high. It begins with an unexpectedly heady, almost psychedelic stimulus that can enhance sensory perception. This cerebral onset quickly transitions into a powerful, "sticks to the bones" body high that melts away tension and provides deep, long-lasting relaxation. Cultivation Preferences - Flowering Time: Approximately 8 to 9 weeks. - Environment: Thrives in both indoor and outdoor settings, though it prefers stable, warm climates similar to its Hawaiian origin. - Yield: Moderate to high, rewarding growers who provide consistent nutrients and proper airflow to its dense buds.Origin The strain originated in Hawaii, where its genetics were first collected. It was later brought to Colorado, where Colorado Seed Inc. stabilized the lineage for commercial and craft cultivation. Seed Suppliers Authentic seeds are primarily associated with Colorado Seed Inc. Due to its rare status, clones or seeds may also be found through specialized boutique nurseries in Colorado and select West Coast dispensaries. Conclusion Blue Trane is a standout choice for those seeking a strain with a mysterious history and a potent, multi-layered experience. Its transition from a trippy mental state to a deep physical stone makes it an excellent option for evening use or for connoisseurs looking to explore the unique influence of Hawaiian-sourced genetics. Previous Next

Everything about London Cake: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back London Cake Strain Review Type Hybrid THC % 19% Dominant Terpene Energy Terpinolene Unknown Overview London Cake is a premium indica-dominant hybrid marijuana strain known for its decadent flavor profile and relaxing properties. Often compared to other "Cake" varieties, it has gained popularity among connoisseurs for its dessert-like qualities and consistent potency. Effects London Cake is an indica-dominant hybrid that delivers a balanced high, starting with a gentle cerebral lift that induces euphoria and mental clarity before transitioning into a soothing body stone. This calming progression makes it ideal for managing stress, anxiety, and mild physical pain without causing immediate, heavy sedation. Its terpene profile is led by limonene, which provides mood-elevating effects; caryophyllene, which assists with physical discomfort and inflammation; and myrcene, which promotes deep relaxation and an earthy aroma. These characteristics make London Cake a versatile choice for users seeking a luxurious sensory experience that balances mental stimulation with physical ease. Positive Effects Side Effects Common Uses Relaxed 0% Happy 0% Euphoric 0% Uplifted 0% Talkative 0% Creative 0% Energetic 0% Focused 0% Giggly 0% Tingly 0% Hungry 0% Sleepy 0% Unknown Dry Mouth 0% Dry Eyes 0% Dizzy 0% Paranoid 0% Anxious 0% Hungry 0% Tingly 0% Sleepy 0% Appearance The buds of London Cake are typically dense and spade-shaped, featuring a deep forest green color with purple undertones. They are adorned with thin, fiery orange pistils and a heavy, sparkling coating of tiny white crystal trichomes that give the flowers a sticky, resinous texture. Aroma London Cake emits a rich and inviting aroma dominated by sweet, doughy notes reminiscent of freshly baked goods. This scent is complemented by a pungent earthy base and subtle hints of sour citrus and berries. Flavor The flavor is a highlight for many users, offering a smooth, creamy smoke that tastes like vanilla cake and sweet berries. On the exhale, it leaves a lingering nutty and slightly spicy aftertaste with a touch of herbal pine. Lineage While specific breeder information can vary, London Cake is generally believed to be a cross between London Pound Cake and another potent "Cake" or "Cookie" strain. This genetic heritage contributes to its high THC content and robust terpene profile. Terpene Profile - Limonene: Provides a bright citrus note and potentially mood-elevating effects. - Caryophyllene: Adds a spicy, peppery kick and may help with physical discomfort. - Myrcene: Contributes to the earthy aroma and promotes deep relaxation.Effects London Cake delivers a balanced high that begins with a gentle cerebral lift, inducing feelings of euphoria and mental clarity. As the high progresses, a soothing body stone takes over, easing muscle tension and promoting a sense of calm. It is frequently used to manage stress, anxiety, and mild physical pain without causing immediate sedation. Cultivation Preferences London Cake is best suited for growers with some experience. It can be cultivated both indoors and outdoors, though it requires a controlled environment to maximize resin production. - Flowering Time: Approximately 8 to 9 weeks. - Yield: Moderate to high. - Climate: Prefers a warm, semi-humid climate with consistent pruning to allow light to reach lower bud sites.Origin The strain likely originated in the United States, emerging from the West Coast's vibrant breeding scene where "dessert" strains have been highly refined over the last decade. Seed Suppliers Authentic seeds or clones of London Cake can often be found through specialty breeders and seed banks such as Seed City, Neptune Seed Bank, or local nurseries in legal markets. Conclusion London Cake is an excellent choice for those seeking a flavorful, indica-leaning experience that balances mental stimulation with physical relaxation. Its complex terpene profile and stunning bag appeal make it a standout addition to any collection, providing a luxurious sensory experience from start to finish. Previous Next

Illinois cannabis revenue fell 13% to $1.5 billion in 2024 despite a surge in item sales, driven by average flower prices dropping from over $400 to $167 per ounce since 2020. The state currently employs 17,000 industry workers and generated $438 million in dispensary taxes for fiscal year 2025, while officials have paused new licensing as they approach a 500-license cap. < Back Illinois Cannabis Revenues Down 13% Despite More Items Sold Feb 19, 2026 Source: TG Branfalt Ganjapreneur Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Cannabis sales revenues in Illinois declined 13% last year to $1.5 billion, according to state data outlined by the Chicago Tribune. Despite the revenue slump, the number of cannabis items sold in the state spiked to 58 million in 2024, which reflects lower overall prices. When adult-use cannabis sales launched in the state in 2020, the average price per ounce of flower was more than $400; by the end of last year, the average price was about $167, the report says. In 2025, Michigan’s cannabis market experienced a similar trend with retailers selling 260,000 more pounds of cannabis in 2025 than in 2024, but sales totaling about $3.17 billion – $113 million less than the 2024 sales total. According to Illinois’ 2025 Annual Cannabis Report, the state’s cannabis industry counts about 9,000 dispensary employees licensed statewide, and nearly 8,000 more in cultivation operations. Dispensary taxes generated $438 million for fiscal year 2025, according to the report. Last year, state officials indicated they would pause the issuance of new cannabis industry licenses as they near the 500-license cap in order to give current operators time to mature. Chicago lawmakers recently sought to ban most hemp-derived THC products from sale in the city – which may have helped bolster licensed adult-use cannabis sales – but Mayor Brandon Johnson last week vetoed that bill worried about “potential negative impacts” of a “prohibition-style ban.” < Previous Next > Recent Reviews Cookies & Alt Sol "Ridgeline Lantz" Strain Review - Takoma Wellness Center Ridgeline Lantz, cultivated by Alt Sol and currently available at Takoma Wellness Center, exudes an impressive pedigree. With its origins... Watermelon Sugar, High: Fade Co.'s Live Resin Gummies Reviewed There's a running joke about Harry Styles' summer smash that the man himself has cheerfully leaned into: nobody is entirely sure what "watermelon sugar" is, only that it sounds fantastic and you want more of it. Fade Co. seems to have taken that ambiguity as a design brief. Their new live resin gummies don't just borrow the fruit - they capture the whole breezy, sun-warmed, slightly-too-good-to-analyze feeling the song trades in, then pack it ten to a tin... Platinum TK - Green Theory Dispensary Platinum TK is an indica-dominant hybrid from the skilled cultivators at Alt Sol that offers a robust and relaxing experience. Currently... 1 2 3 4 5

Everything about Animal Cocktail: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back Animal Cocktail Strain Review Type Hybrid THC % 20% Dominant Terpene Energy NA Unknown Overview Animal Cocktail is a premium, well-balanced hybrid cannabis strain celebrated for its complex sensory profile and versatile effects. Often reaching THC levels between 20% and 28%, it is favored by veteran users seeking a potent experience that harmonizes cerebral stimulation with physical relaxation. Effects Animal Cocktail is a potent hybrid strain that delivers a balanced experience, beginning with a creeping cerebral lift that induces happy, giggly euphoria and enhanced creativity. As the high progresses, it transitions into a calming body buzz that provides deep relaxation without immediate sedation, making it suitable for moderate energy levels during afternoon or evening use. This strain is highly effective for managing ailments such as stress, chronic pain, and depression. Its complex profile is driven by a terpene blend led by limonene, which offers citrusy notes and mood elevation; caryophyllene, which adds a peppery kick and anti-inflammatory benefits; and myrcene, which contributes earthy undertones and supports physical relaxation. Together, these elements make Animal Cocktail a versatile choice for those seeking both mental stimulation and soothing physical relief. Positive Effects Side Effects Common Uses Relaxed 0% Happy 0% Euphoric 0% Uplifted 0% Talkative 0% Creative 0% Energetic 0% Focused 0% Giggly 0% Tingly 0% Hungry 0% Sleepy 0% Unknown Dry Mouth 0% Dry Eyes 0% Dizzy 0% Paranoid 0% Anxious 0% Hungry 0% Tingly 0% Sleepy 0% Appearance The buds of Animal Cocktail are typically dense, medium-sized, and visually striking. They often showcase a vibrant palette of forest greens and deep purple undertones, all heavily frosted in a thick layer of sticky, white crystalline trichomes. Bright orange pistils weave through the foliage, adding to its shelf appeal. Aroma This strain features a pungent and multi-layered fragrance. It is characterized by a "funky" and skunky base, often described as having notes of peanut oil and sharp pine. This savory profile is balanced by sweet, doughy, and creamy vanilla scents inherited from its cookie-descendant lineage. Flavor The taste profile mirrors its aroma, delivering a smooth smoke with a sophisticated blend of sweet fruitiness and earthy spice. On the inhale, users often detect a sugary, dessert-like richness, while the exhale reveals more herbal, peppery, and slightly garlicky undertones. Lineage Animal Cocktail is a cross between the potent Animal Face and the savory Garlic Cocktail. Other variations of the lineage are noted as a cross between Animal Cookies and an unknown hybrid or Animal Cookies and Lemon Tree, though the Animal Face x Garlic Cocktail cross is the most recognized "veteran" genetic. Terpene Profile - Limonene: The most abundant terpene, providing a citrusy brightness and contributing to mood elevation and stress relief. - Caryophyllene: Adds a peppery kick and offers potential anti-inflammatory benefits. - Myrcene: Provides earthy notes and supports the strain’s relaxing physical effects.Effects The high begins with a creeping cerebral lift, inducing a state of happy, giggly euphoria and enhanced creativity. As the experience progresses, a calming body buzz sets in, providing deep relaxation without immediate sedation. It is effective for managing stress, chronic pain, and depression, making it suitable for both afternoon and evening use. Cultivation Preferences - Flowering Time: Approximately 53 to 64 days. - Yield: Moderate to high; indoor yields average around 400g/m², while outdoor plants can produce roughly 400g per plant. - Climate: Prefers stable temperatures and moderate humidity. Regular pruning is recommended to improve airflow and light penetration to the dense lower buds.Origin Originally bred by Uprising Seed Company, Animal Cocktail emerged from the modern breeding scene focused on combining "gas" and "funk" profiles with the sweet characteristics of dessert strains. Seed Suppliers Authentic genetics can be found through specialized breeders like Uprising Seed Company and are occasionally available through boutique nurseries such as Skord or House of Kush. Conclusion Animal Cocktail is a standout hybrid for connoisseurs who appreciate a "funky" alternative to standard dessert strains. Its balance of uplifting mental energy and soothing physical effects makes it a versatile choice for a wide range of therapeutic and recreational needs. Previous Next

Ohio state Sen. Bill DeMora introduced Senate Bill 266 to ban the sale of intoxicating hemp products to individuals under 21 and prohibit products attractive to children or untested under marijuana rules. This bill focuses solely on hemp, separating it from marijuana law changes. Other bills, such as Ohio Senate Bill 86 and Senate Bill 56, also aim to regulate intoxicating hemp products, with some including taxation, sales restrictions, and changes to marijuana laws. Ohio House Bill 160 primarily addresses marijuana law changes but includes a provision for THC products to be sold only at regulated dispensaries. These legislative efforts come as Ohio, like many states, lacks regulations around intoxicating hemp products despite legal recreational marijuana sales since August 2024. < Back New Ohio Bill Would Prohibit Intoxicating Hemp Sales to Minors Oct 5, 2025 Source: Marijuana Moment Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Ohio lawmakers are taking aim at the "wild west" of intoxicating hemp products with a wave of new legislative proposals. Leading the charge is Senator Bill DeMora’s Senate Bill 266, which specifically targets the sale of delta-8 and similar hemp derivatives to anyone under 21. Beyond age limits, the bill seeks to scrub store shelves of "copycat" packaging that mimics popular candy or uses cartoons to appeal to kids. While other pending bills like SB 86 and SB 56 attempt to bundle hemp regulation with changes to the state's voter-approved marijuana laws, DeMora’s approach keeps them separate to fast-track safety standards and testing. For the cannabis community, this shift toward regulation is actually a win. While some fear "over-regulation," establishing lab-testing requirements and clear age gates helps legitimate businesses thrive and ensures that what we're consuming is actually safe. By moving these products into regulated dispensaries or under strict oversight, we move away from shady gas station alternatives and toward a more transparent, professional market that protects both the industry's reputation and our youth. < Previous Next > Recent Reviews Cookies & Alt Sol "Ridgeline Lantz" Strain Review - Takoma Wellness Center Ridgeline Lantz, cultivated by Alt Sol and currently available at Takoma Wellness Center, exudes an impressive pedigree. With its origins... Watermelon Sugar, High: Fade Co.'s Live Resin Gummies Reviewed There's a running joke about Harry Styles' summer smash that the man himself has cheerfully leaned into: nobody is entirely sure what "watermelon sugar" is, only that it sounds fantastic and you want more of it. Fade Co. seems to have taken that ambiguity as a design brief. Their new live resin gummies don't just borrow the fruit - they capture the whole breezy, sun-warmed, slightly-too-good-to-analyze feeling the song trades in, then pack it ten to a tin... Platinum TK - Green Theory Dispensary Platinum TK is an indica-dominant hybrid from the skilled cultivators at Alt Sol that offers a robust and relaxing experience. Currently... 1 2 3 4 5

Hawaii Gov. Josh Green (D) vetoed a bill allowing telehealth for medical cannabis patients, citing privacy concerns. The bill also addressed penalties for unlicensed dispensaries and prohibited cannabis cultivation without permits. Green's message didn't oppose other provisions but supports expanding medical cannabis access. House lawmakers targeted shops selling intoxicating hemp products, noting over 84 "illegal dispensary operators." < Back Hawaii Gov. Vetoes Medical Cannabis Telehealth Bill Over Privacy Concerns Jun 12, 2025 Source: TG Branfalt Ganjapreneur Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Hawaii Gov. Josh Green (D) has vetoed a bill that would have allowed medical cannabis patients to get certified by a physician for the state’s cannabis program via telehealth, established criminal penalties for unlicensed operation of a medical cannabis dispensary, and prohibited cannabis cultivation without a Department of Health-issued permit. In his veto message, Green, a medical doctor, focused on the bill’s telehealth provisions, claiming that they authorize “the inspection of patients’ medical records without warrant,” which constitutes “a grave violation of privacy.” “Given that the federal government classifies cannabis as a Schedule I substance, patients’ reasonable fears of repercussions based upon information gained from inspection of their personal medical records may deter patients from participating in the medical cannabis program.” — Green in the veto message The message did not outline any opposition to other provisions in the bill but noted that Green’s administration “remains committed to Hawai‘i’s existing medical cannabis program and supports efforts to expand access to medical cannabis for any medical condition.” In April, Hawaii House lawmakers took aim at shops selling intoxicating hemp-derived products. In a resolution, the chamber said that there are more than 84 “illegal dispensary operators” in the state and that the number is increasing “exponentially.” The bill vetoed by Green focused on illegally operating medical cannabis dispensaries, but did not address shops selling intoxicating hemp products. < Previous Next > Recent Reviews Cookies & Alt Sol "Ridgeline Lantz" Strain Review - Takoma Wellness Center Ridgeline Lantz, cultivated by Alt Sol and currently available at Takoma Wellness Center, exudes an impressive pedigree. With its origins... Watermelon Sugar, High: Fade Co.'s Live Resin Gummies Reviewed There's a running joke about Harry Styles' summer smash that the man himself has cheerfully leaned into: nobody is entirely sure what "watermelon sugar" is, only that it sounds fantastic and you want more of it. Fade Co. seems to have taken that ambiguity as a design brief. Their new live resin gummies don't just borrow the fruit - they capture the whole breezy, sun-warmed, slightly-too-good-to-analyze feeling the song trades in, then pack it ten to a tin... Platinum TK - Green Theory Dispensary Platinum TK is an indica-dominant hybrid from the skilled cultivators at Alt Sol that offers a robust and relaxing experience. Currently... 1 2 3 4 5

President Trump is reportedly planning an executive order to fund research into the therapeutic benefits of ibogaine for treating PTSD and traumatic brain injuries, particularly among veterans. This initiative aligns with broader administration efforts to expand access to psychedelic therapies for mental health conditions like depression and addiction. < Back White House Set to Greenlight Federal Research Into Ibogaine's Healing Potential Apr 16, 2026 Source: Tom Angell Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The federal government is signaling a major shift in how it views alternative plant medicines, and this time the focus is on a powerful psychedelic called ibogaine. Reports indicate that an executive order is in the works that would officially open the door for federal funding and research into this unique substance. While it isn't a full rescheduling move just yet, it’s a massive step toward legitimizing a plant that many in our community have known about for years. The heart of this initiative is focused on helping those who have sacrificed the most. The administration is looking at how ibogaine can help treat PTSD and traumatic brain injuries, particularly for veterans who haven't found relief through traditional means. For anyone who follows the natural wellness space, this is incredibly exciting news. It means the government is finally moving past the old stigmas to see if these substances can truly offer a lifeline to those struggling with mental health and addiction. This isn't just happening in a vacuum. We’ve already seen states like Texas take the lead by launching their own research programs when private industry couldn't quite get the ball rolling. Now, with federal support and potential funding on the horizon, the pace of discovery is set to accelerate. High-ranking officials are expressing a real urgency to create safe, therapeutic pathways for access, potentially including other substances like psilocybin and MDMA in the near future. For the everyday enthusiast, this matters because it represents a broader trend of "plant over pills." As the walls of prohibition continue to crumble—much like we've seen with the ongoing push for cannabis rescheduling—the options for natural, effective wellness are expanding. It’s always a good idea to stay informed and talk to professionals if you’re exploring these paths, but seeing the federal government prioritize this kind of research is a huge win for accessibility and the future of holistic health. < Previous Next > Recent Reviews Cookies & Alt Sol "Ridgeline Lantz" Strain Review - Takoma Wellness Center Ridgeline Lantz, cultivated by Alt Sol and currently available at Takoma Wellness Center, exudes an impressive pedigree. With its origins... Watermelon Sugar, High: Fade Co.'s Live Resin Gummies Reviewed There's a running joke about Harry Styles' summer smash that the man himself has cheerfully leaned into: nobody is entirely sure what "watermelon sugar" is, only that it sounds fantastic and you want more of it. Fade Co. seems to have taken that ambiguity as a design brief. Their new live resin gummies don't just borrow the fruit - they capture the whole breezy, sun-warmed, slightly-too-good-to-analyze feeling the song trades in, then pack it ten to a tin... Platinum TK - Green Theory Dispensary Platinum TK is an indica-dominant hybrid from the skilled cultivators at Alt Sol that offers a robust and relaxing experience. Currently... 1 2 3 4 5